Basit öğe kaydını göster

dc.contributor.authorÇapan, İrfan
dc.contributor.authorHawash, Mohammed
dc.contributor.authorQaoud, Mohammed T.
dc.contributor.authorGülüm, Levent
dc.contributor.authorTunoğlu, Ezgi Nurdan Yenilmez
dc.contributor.authorÇifci, Kezban Uçar
dc.contributor.authorÇevrimli, Bekir Sıtkı
dc.contributor.authorSert, Yusuf
dc.contributor.authorServi, Süleyma
dc.contributor.authorKoca, İrfan
dc.contributor.authorTutar, Yusuf
dc.date.accessioned2024-06-12T11:10:24Z
dc.date.available2024-06-12T11:10:24Z
dc.date.issued2024en_US
dc.identifier.citationÇapan, İ., Hawash, M., Qaoud, M. T., Gülüm, L., Tunoglu, E. N. Y., Çifci, K. U., Çevrimli, B. S., Sert, Y., Servi, S., Koca, İ., & Tutar, Y. (2024). Synthesis of novel carbazole hydrazine-carbothioamide scaffold as potent antioxidant, anticancer and antimicrobial agents. BMC chemistry, 18(1), 102. https://doi.org/10.1186/s13065-024-01207-1en_US
dc.identifier.issn2661-801X
dc.identifier.urihttps://doi.org/10.1186/s13065-024-01207-1
dc.identifier.urihttps://hdl.handle.net/11436/9091
dc.description.abstractBackground: Carbazole-based molecules containing thiosemicarbazide functional groups are recognized for their diverse biological activities, particularly in enhancing therapeutic anticancer effects through inhibiting crucial pathways. These derivatives also exhibit noteworthy antioxidant properties. Objectives: This study aims to synthesize, characterize, and evaluate the antioxidant and anticancer activities of 18 novel carbazole derivatives. Methods: The radical scavenging capabilities of the compounds were assessed using the 2,2-diphenyl-1-picrylhydrazyl assay. Antiproliferative activities were evaluated on MCF-7 cancer cell lines through viability assays. Additionally, the modulation of the PI3K/Akt/mTOR pathway, apoptosis/necrosis induction, and cell cycle analysis were conducted for the most promising anticancer agents. Results: nine compounds showed potent antioxidant activities with IC50 values lower than the positive control acarbose, with compounds 4 h and 4y exhibiting the highest potency (IC50 values of 0.73 and 0.38 µM, respectively). Furthermore, compounds 4o and 4r displayed significant anticancer effects, with IC50 values of 2.02 and 4.99 µM, respectively. Compound 4o, in particular, exhibited promising activity by targeting the PI3K/Akt/mTOR signaling pathway, inhibiting tumor survival, inducing apoptosis, and causing cell cycle arrest in MCF-7 cell lines. Furthermore, compound 4o was showed significant antimicrobial activities against S. aureus and E. coli, and antifungal effect against C. albicans. Its potential to overcome drug resistance through this pathway inhibition highlights its promise as an anticancer agent. Molecular docking simulations supported these findings, revealing favorable binding profiles and interactions within the active sites of the enzymes PI3K, AKT1, and mTOR. Moreover, assessing the druggability of the newly synthesized thiosemicarbazide derivatives demonstrated optimal physicochemical properties, further endorsing their potential as drug candidates.en_US
dc.language.isoengen_US
dc.publisherBioMed Central Ltd.en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectAnticanceren_US
dc.subjectAntioxidanten_US
dc.subjectCarbazoleen_US
dc.subjectMolecular dockingen_US
dc.subjectPI3K/Akt/mTOR pathwayen_US
dc.subjectThiosemicarbazideen_US
dc.titleSynthesis of novel carbazole hydrazine-carbothioamide scaffold as potent antioxidant, anticancer and antimicrobial agentsen_US
dc.typearticleen_US
dc.contributor.departmentRTEÜ, Tıp Fakültesi, Temel Tıp Bilimleri Bölümüen_US
dc.contributor.institutionauthorTutar, Yusuf
dc.identifier.doi10.1186/s13065-024-01207-1en_US
dc.identifier.volume18en_US
dc.identifier.issue1en_US
dc.identifier.startpage102en_US
dc.relation.journalBMC Chemistryen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster